EGFR mutation in gefitinib-responsive small-cell lung cancer

被引:93
作者
Okamoto, I [1 ]
Araki, J
Suto, R
Shimada, M
Nakagawa, K
Fukuoka, M
机构
[1] Kinki Univ, Sch Med, Dept Med Oncol, Osaka 589, Japan
[2] Yamaguchi Gen Med Ctr, Dept Resp Med, Yamaguchi, Japan
[3] TSL, Tokyo, Japan
关键词
D O I
10.1093/annonc/mdj114
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1028 / U9
页数:2
相关论文
共 5 条
[1]   Somatic mutations of EGFR in colorectal cancers and glioblastomas [J].
Barber, TD ;
Vogelstein, B ;
Kinzler, KW ;
Velculescu, VE .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (27) :2883-2883
[2]   Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib [J].
Lynch, TJ ;
Bell, DW ;
Sordella, R ;
Gurubhagavatula, S ;
Okimoto, RA ;
Brannigan, BW ;
Harris, PL ;
Haserlat, SM ;
Supko, JG ;
Haluska, FG ;
Louis, DN ;
Christiani, DC ;
Settleman, J ;
Haber, DA .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) :2129-2139
[3]   EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy [J].
Paez, JG ;
Jänne, PA ;
Lee, JC ;
Tracy, S ;
Greulich, H ;
Gabriel, S ;
Herman, P ;
Kaye, FJ ;
Lindeman, N ;
Boggon, TJ ;
Naoki, K ;
Sasaki, H ;
Fujii, Y ;
Eck, MJ ;
Sellers, WR ;
Johnson, BE ;
Meyerson, M .
SCIENCE, 2004, 304 (5676) :1497-1500
[4]   EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib [J].
Pao, W ;
Miller, V ;
Zakowski, M ;
Doherty, J ;
Politi, K ;
Sarkaria, I ;
Singh, B ;
Heelan, R ;
Rusch, V ;
Fulton, L ;
Mardis, E ;
Kupfer, D ;
Wilson, R ;
Kris, M ;
Varmus, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (36) :13306-13311
[5]  
Tanno S, 2004, ONCOL REP, V12, P1053